BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3546956)

  • 21. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
    Roodman GD; LeMaistre CF; Clark GM; Page CP; Newcomb TF; Knight WA
    Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
    Dominietto A; Raiola AM; van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Frassoni F; Casarino L; Verdiani S; Bacigalupo A
    Br J Haematol; 2001 Jan; 112(1):219-27. PubMed ID: 11167808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.
    Broxmeyer HE; Hangoc G; Cooper S; Ribeiro RC; Graves V; Yoder M; Wagner J; Vadhan-Raj S; Benninger L; Rubinstein P
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4109-13. PubMed ID: 1373894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte progenitor compartments after allogeneic bone marrow grafts.
    Faille A; Maraninchi D; Gluckman E; Devergie A; Balitrand N; Ketels F; Dresch C
    Scand J Haematol; 1981 Mar; 26(3):202-14. PubMed ID: 7015477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CFU-Mk content of immunoselected CD34+ peripheral blood progenitor cells, evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors.
    Boiret N; Kanold J; Fouassier M; Bons JM; Halle P; Rapatel C; Berger J; Pireyre P; Blanzat V; Travade P; Bonhomme J; Demeocq F; Berger MG
    J Hematother Stem Cell Res; 2000 Aug; 9(4):525-34. PubMed ID: 10982252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of ganciclovir and astragalus membranaceus on proliferation of hematopoietic progenitor cells of cord blood after cytomegalovirus infection in vitro].
    Liu WJ; Liu B; Guo QL; Zhang YC; Yuan YJ; Fu XD; Deng ZH; Lin J
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):490-4. PubMed ID: 15324563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of post-thaw infused cell dose for predicting engraftment after unrelated cord blood transplantation].
    Wu JY; Liao C; Chen JS; Xu ZP; Li Y; Sun X; Wu SQ; Tang XW; Lu Y; Xie GE
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):754-8. PubMed ID: 21729565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemopoietic progenitor cell function after HLA-identical sibling bone marrow transplantation: influence of chronic graft-versus-host disease.
    Atkinson K; Norrie S; Chan P; Zehnwirth B; Downs K; Biggs J
    Int J Cell Cloning; 1986 May; 4(3):203-20. PubMed ID: 3517192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the bone marrow cells from an excised pipe bone.
    Takakuwa K; Kurata H; Hirono T; Koike T; Kishi K; Shibata A; Tanaka K
    Hematol Pathol; 1993; 7(2):107-18. PubMed ID: 8340284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L; Lopez M; Gorin NC; Nauman A; Giarratana MC; Laporte JP; Stachowiak J; Salmon C; Duhamel G
    Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation.
    de Witte T; Raymakers R; Plas A; Koekman E; Wessels H; Haanen C
    Transplantation; 1984 Feb; 37(2):151-5. PubMed ID: 6364497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
    Rowley SD; Zuehlsdorf M; Braine HG; Colvin OM; Davis J; Jones RJ; Saral R; Sensenbrenner LL; Yeager A; Santos GW
    Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.